Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2011 Results
Date:8/4/2011

ax provision

(1,250)7,437(8,687)-117%Tax provision (benefit)

(45)5,268(5,313)-101%Net income (loss)

(1,205)1,809(3,014)-167%Diluted net income (loss) per share

$
(0.04)$
.06$
(0.10)-167%Second Quarter 2011 Key Financial Figures(1) Three Months Ended June 30March 31(in thousands, except per share amounts)

20112011  Change ($)Change (%)Total revenues

$
7,430$
7,501$
(71)-1%Research & development  expenses

5,9994,2671,73241%General & administrative expenses

2,5722,858(286)-10%Non-cash stock-based compensation(2)

1,3251,604(279)-17%Income (loss) before tax provision

(1,392)142(1,534)NATax provision (benefit)

(51)6(57)NANet income (loss)

(1,341)136(1,477)NADiluted net income (loss) per share

$
(0.05)$
.00$
(0.05)NASelect Cash Flow Data(1)
 (in thousands)

 Six Months Ending June 30June 3020112010Net cash provided by (used in)Operating activities

(8,883)(728)Investing activities

16,710(61,311)Financing activities

-2,395Net change in cash and cash equivalents

$
7,827$
(59,644)Select Balance Sheet Data(1) June 30March 31June 30(in thousands)

201120112010Total cash and marketable securities

$
88,399$
94,555$
207,117(1) Unaudited

(2) Non-cash stock-based compensation is allocated to both Research & development and General & administrative expenses OPERATIONAL HIGHLIGHTS   Fanapt® prescriptions, as reported by IMS, reached 30,000 in the second quarter of 2011.  This represents a 17% increase over first quarter 2011 prescriptions.  Since its launch in January 2010, over 110,000 Fanapt® prescriptions have been written in the U.S.

Vanda continues its effort to expand the availability of Fanapt® to markets outside the U.S. and Canada.  On July 22, 2011, the European Me
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... third international medical cannabis conference taking place at ... France , on October 22, 2014.  The ... stakeholders, such as researchers, health professionals, and patients, ...
(Date:8/22/2014)... -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the pricing ... stock and warrants at a price of $10,000 per ... deducting underwriting discounts and commissions and offering expenses payable ... separable and will be issued separately.  The shares of ... NASDAQ Stock Market under the ticker symbol "WGBS" on ...
(Date:8/21/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... health, has appointed Holly B. Bauzon as ... Ms. Bauzon has a proven track record in both ... services companies. She has more than 20 years of ... held the position of Director, Lab Services Sales and ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... 22 The American Association of Oral and ... paper on Bisphosphonate-Related Osteonecrosis of the Jaw to ... this condition. BRONJ appears as a non-healing exposed ... patients undergoing intravenous cancer-related bisphosphonate therapy or more ...
... a full service and,leading clinical research organization (CRO), today ... S.r.l., a CRO focused on Phase I to,Phase IV ... http://www.newscom.com/cgi-bin/prnh/20080122/335477 ) , The ... have legal and,operating offices in Milan, Italy. The combined ...
Cached Medicine Technology:AAOMS Updates BRONJ Position Paper 2AAOMS Updates BRONJ Position Paper 3Phidea Srl and Marvin Research Srl Announce Completion of Merger 2Phidea Srl and Marvin Research Srl Announce Completion of Merger 3
(Date:8/22/2014)... This report studies the "Sample Preparation Market ... (Tubes), Kits (Isolation, Purification), By Application (Genomics, Proteomics), ... to 2018" This market was valued at $4,254.8 ... at a CAGR of 5.9% from 2013 to ... Browse 98 market data Tables and 23 Figures ...
(Date:8/22/2014)... With the stage set for the ... Expo - which will be held in Boston August ... in its online opinion section, Podium. The op-ed ... co-authored by Steven C. Anderson, IOM, CAE, president & ... the MCPHS University School of Pharmacy – Worcester/Manchester. ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Millennium Treatment Group ... resulting in a high level of drug use among teenagers. ... fight against drug addiction and work to minimize drug abuse. ... of alcohol and drug addiction in history. According to the ... estimated 23.9 million Americans aged 12 or older—or 9.2 percent ...
(Date:8/22/2014)... Indiana (PRWEB) August 22, 2014 The ... Toyota Indiana is on the grow again. ... 300 jobs by summer 2016 to boost production of ... will bring Toyota Indiana’s overall investment to $4 billion. ... North America while providing additional flexibility to adjust its ...
(Date:8/22/2014)... Medicine team has found that targeted automated alerts ... infections in hospital patients with urinary catheters. In ... simplified, the rate of improvement dramatically increased. , ... need urinary catheters in the first place and ... catheters that have not been removed within a ...
Breaking Medicine News(10 mins):Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Sample Preparation Market by Product and Application Worth $5,672 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3
... School of Massage, taking the National Certification Examination for Therapeutic Massage ... points higher than the national average. , ... Atlanta, ... Massage (atlantaschoolofmassage.com), taking the National Certification Examination for Therapeutic Massage for ...
... Recall included Famous Amos and Keebler peanut butter cookies; ... ; toll now stands at 452 sick in 43 ... , , FRIDAY, Jan. 16 (HealthDay News) -- Cereal giant ... as U.S. health officials expanded their investigation into peanut ...
... Database, 85 percent of hospitals in the contracting phase of an IT ... when CCHIT released its first acute care or inpatient certified products. ... ... HIMSS Analytics Database, 85 percent of hospitals in the contracting phase of ...
... products; toll now stands at 452 sick in 43 states ... Jan. 16 (HealthDay News) -- U.S. health officials said Friday ... contaminated with salmonella, as the toll from the outbreak climbed ... Canada, and possibly six deaths. , , U.S. Food and ...
... Group announces a former Harris Interactive executive has joined to ... to announce the appointment of J. Scott Moller, M.S. as ... Mr. Moller has a BA in Economics and Political Science ... from the University of Rochester . Before joining ...
... trumps violent content among gamers, study finds , , FRIDAY, ... video game, not the violence or gore it depicts, that ... Bloodiness, in fact, actually detracts from a game,s "fun factor" ... of Rochester and Immersyve Inc., a firm that researches gamers, ...
Cached Medicine News:Health News:Atlanta School of Massage Grads Beat National Test Scores By Wide Margin 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 4Health News:85 Percent of Hospitals Select CCHIT Certified Products 2Health News:85 Percent of Hospitals Select CCHIT Certified Products 3Health News:85 Percent of Hospitals Select CCHIT Certified Products 4Health News:85 Percent of Hospitals Select CCHIT Certified Products 5Health News:FDA Widens Peanut Butter-Salmonella Probe 2Health News:FDA Widens Peanut Butter-Salmonella Probe 3Health News:KJT Group L.L.C. Continues Solid Growth 2Health News:Game, Not Gore, Keeps Video Players Playing 2
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Barraquer needle holder, curved, delicate....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: